{"version":"1.0","type":"link","title":"Clarifying the survival impact of immunotherapy in HR+/HER2- metastatic breast cancer: methodological caveats from a real-world perspective - Letter to the Editor.","author_name":"Sun M 외","author_url":"https://prs-insight.online/author/Sun%20M","provider_name":"PRSinsight","provider_url":"https://prs-insight.online","thumbnail_url":"https://prs-insight.online/og/paper/87341","thumbnail_width":1200,"thumbnail_height":630}